Evidence map›Paper›PMID 36825085›Full record

ArticleFrontiers in microbiology2023

Construction of

Bing Wang, Xiang Zhou, Wei Liu, Mei-Han Liu, Dan Mo, Qing-Feng Wu, Ya-Juan Wang, Miao-Miao Zhang, Lei Chen, Shan Yuan and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Advances in the biological production of butyric acid.World journal of microbiology & biotechnology · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Bing WangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Xiang ZhouInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Wei LiuCAS Key Laboratory of Bio-Based Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, Shandong, China.
Mei-Han LiuInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Dan MoInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Qing-Feng WuInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Ya-Juan WangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Miao-Miao ZhangInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Lei ChenCollege of Food and Bioengineering, Henan University of Science and Technology, Luoyang, Henan, China.
Shan YuanCAS Key Laboratory of Bio-Based Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, Shandong, China.
Bo ZhouCollege of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, China.
Xin LiCollege of Food and Bioengineering, Henan University of Science and Technology, Luoyang, Henan, China.
Dong LuInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Chinese Academy of Sciences · CNCentral South University of Forestry and Technology · CNHenan University of Science and Technology · CNInstitute of Modern Physics · CNUniversity of Chinese Academy of Sciences · CNQingdao Institute of Bioenergy and Bioprocess Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, an acid-base treatment combined with a new green membrane treatment technology - a dynamic ion-exchange membrane -was used to pretreat refinery final molasses, so that it could be used for Results and discussion: This means that refinery final molasses from the sugar industry could be utilized as a high-value by-product and used for the growth of

Indexed as

adaptive evolutionbutyric acidClostridium tyrobutyricumionic membranerefinery final molasses

Identifiers

PMID36825085
PMCPMC9941566
OpenAlexW4319442688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.